España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Halozyme Therapeutics
HALO
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$46.96
-0.36
-0.76%
At close: -
$46.96
0.00
0.00%
After Hours: Dec 20, 4:06 PM EDT
Get Report
Comment
Halozyme Therapeutics (HALO) Forecast
News
Earnings
Halozyme Therapeutics (HALO) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Halozyme Therapeutics (NASDAQ:HALO) Stock
Halozyme Therapeutics Stock (NASDAQ: HALO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, December 18, 2024
9 Analysts Have This To Say About Halozyme Therapeutics
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Halozym...
Benzinga Newsdesk
Wednesday, December 11, 2024
(HALO) - Analyzing Halozyme Therapeutics's Short Interest
Benzinga Insights
Monday, November 25, 2024
HC Wainwright & Co. Reiterates Buy on Halozym...
Benzinga Newsdesk
Friday, November 22, 2024
Halozyme Withdraws Evotec Bid After Rebuff, Reaffirms Strong Growth Outlook
Nabaparna Bhattacharya
Halozyme Therapeutics shares are trading high...
Benzinga Newsdesk
Halozyme Withdraws €2B Proposal To Acquire Ev...
Benzinga Newsdesk
Wednesday, November 20, 2024
Breaking Down Halozyme Therapeutics: 10 Analysts Share Their Views
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Halozym...
Benzinga Newsdesk
Friday, November 15, 2024
Halozyme Therapeutics shares are trading lowe...
Benzinga Newsdesk
Large Pharma Partner Halozyme Therapeutics Offers To Acquire Germany-Based Evotec For ~$2 Billion
Vandana Singh
Thursday, November 14, 2024
Evotec Confirms Receipt Of Non-binding Expres...
Benzinga Newsdesk
Evotec shares are trading higher after the co...
Benzinga Newsdesk
Halozyme Confirms Proposal To Combine With Ev...
Benzinga Newsdesk
Evotec Is Said To Attract Takeover Interest F...
Benzinga Newsdesk
Tuesday, November 05, 2024
Looking Into Halozyme Therapeutics's Recent Short Interest
Benzinga Insights
Monday, November 04, 2024
Piper Sandler Maintains Neutral on Halozyme T...
Benzinga Newsdesk
Friday, November 01, 2024
Amazon Posts Upbeat Results, Joins Cardinal Health, Waters, Atlassian, Charter Communications, MasTec And Other Big Stocks Moving Higher On Friday
Avi Kapoor
Why Charter Communications Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
Halozyme Therapeutics shares are trading high...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Halozyme...
Benzinga Newsdesk
Thursday, October 31, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Halozyme Therapeutics shares are trading high...
Benzinga Newsdesk
Halozyme Therapeutics Sees FY24 Adj. EPS $4.0...
Benzinga Newsdesk
Halozyme Therapeutics Q3 2024 Adj. EPS $1.27 ...
Benzinga Newsdesk
Wednesday, October 30, 2024
A Look Ahead: Halozyme Therapeutics's Earnings Forecast
Benzinga Insights
Friday, October 25, 2024
Unveiling 12 Analyst Insights On Halozyme Therapeutics
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Halozym...
Benzinga Newsdesk
Thursday, October 24, 2024
Halozyme Therapeutics Says Following Decision...
Benzinga Newsdesk
Monday, October 07, 2024
Halozyme Therapeutics shares are trading lowe...
Benzinga Newsdesk
Wells Fargo Downgrades Halozyme Therapeutics ...
Benzinga Newsdesk
Friday, October 04, 2024
A Glimpse Into The Expert Outlook On Halozyme Therapeutics Through 12 Analysts
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Halozym...
Benzinga Newsdesk
Thursday, October 03, 2024
Halozyme Expands Global Collaboration With Ar...
Benzinga Newsdesk
Thursday, September 19, 2024
JP Morgan Downgrades Halozyme Therapeutics to...
Benzinga Newsdesk
Monday, September 16, 2024
HC Wainwright & Co. Reiterates Buy on Halozym...
Benzinga Newsdesk
Friday, September 13, 2024
(HALO) - Analyzing Halozyme Therapeutics's Short Interest
Benzinga Insights
Roche Group's Genentech Announces FDA Approve...
Benzinga Newsdesk
Critical Insights From Halozyme Therapeutics Analyst Ratings: What You Need To Know
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Halozym...
Benzinga Newsdesk
Reported Earlier, Roche's Genentech And Haloz...
Benzinga Newsdesk
Monday, August 26, 2024
Top 2 Health Care Stocks That May Plunge In August
Avi Kapoor
Tuesday, August 20, 2024
How Is The Market Feeling About Halozyme Therapeutics?
Benzinga Insights
Thursday, August 08, 2024
Benchmark Reiterates Buy on Halozyme Therapeu...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Halozym...
Benzinga Newsdesk
Wednesday, August 07, 2024
TD Cowen Maintains Buy on Halozyme Therapeuti...
Benzinga Newsdesk
Morgan Stanley Maintains Overweight on Halozy...
Benzinga Newsdesk
Halozyme Therapeutics shares are trading high...
Benzinga Newsdesk
Tuesday, August 06, 2024
Halozyme Therapeutics shares are trading high...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch